Browse by Audience
Skip to content
Papers of the Week
Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?
Abstract
A significant association between migraine and restless legs syndrome (RLS) has been reported, and their coexistence is not uncommon. We report a patient with concomitant migraine and RLS who showed improvement of both migraine and RLS symptoms after treatment with galcanezumab, a calcitonin gene-related peptide (CGRP) monoclonal antibody.